Managing diabetes is set to change dramatically by 2026. Endocrinologist reveals 5 cutting-edge technologies that will make care more precise and personalised.

CVS Health will pay $37.76 million to settle allegations it dispensed too many insulin pens to patients, and then obtained improper reimbursements from Medicare, Medicaid and other government ...

CVS Health (CVS) has reached a settlement with the U.S. government, requiring the company to pay $37.76M to resolve claims that it overbilled government healthcare programs for insulin pens. The ...

Rising Diabetes Drives Technological Advancements in North America Insulin Pen Market: Shift to Self-Care and Home-Based Solutions Spurs Growth. North American Insulin Pen Market North American ...

Researchers warn that spending most of our time indoors could be an overlooked risk factor for metabolic diseases ...

From higher wages and cheaper insulin to paper-only grocery bags and expanded renter protections, hundreds of new California ...

California health care faced major cuts in 2025 as federal Medicaid funding dropped and ACA subsidies stalled, threatening ...

Integrated smart technology builds on TempraMed's proven VIVI platform, providing robust Temperature control with medication management for individuals using life-saving medicationHighlights: Expands ...

GLP-1 medicines have been utilised for the treatment of diabetes; however, they are now emerging as important topics for the treatment of obesity ...